Oxaliplatin-induced immune thrombocytopenia in a patient with colon cancer

American Surgeon

Volumn 77, Issue 1, 2011, Pages

  Akdeniz, Aydan ^a   Kucukoztas, Nadire ^a   Yalcin, Selim ^a   Akcali, Zafer ^a   Altundag, Ozden ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IMMUNOGLOBULIN; OXALIPLATIN;

ADULT; ARTICLE; AUTOIMMUNE THROMBOCYTOPENIA; BLEEDING; CASE REPORT; COLON CANCER; FEMALE; HUMAN; LABORATORY TEST; THROMBOCYTE COUNT;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOCOMPROMISED HOST; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS; PYRIDINES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SIGMOID NEOPLASMS; THROMBOCYTOPENIA; WITHHOLDING TREATMENT;

EID: 78651375834     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. James E, Podoltsev N, Salehi E, et al. Oxaliplatin-induced immune thrombocytopenia: another cumulative dose-dependent side effect? Clin Colorectal Cancer 2009;8:220-4.
2. Aster RH. Drug-induced immune thrombocytopenia: an overview of pathogenesis. Semin Hematol 1999;36:2-10.
3. Curtis BR, Kaliszewski J, Marques MB, et al. Immune-mediated thrombocytopenia resulting from sensitivity to oxaliplatin. Am J Hematol 2006;81:193-8. (Pubitemid 43297261)